Hap Trading, LLC Adverum Biotechnologies, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$1.23 - $1.95 $25,338 - $40,170	-20,600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $1,566 - $2,160	-900 Reduced 4.19%	20,600 $1,000
Q3 2021 Nov 10, 2021	BUY	$2.08 - $3.6 $6,032 - $10,440	2,900 Added 15.59%	21,500 $3,000
Q2 2021 Aug 11, 2021	BUY	$3.36 - $10.56 $62,496 - $196,416	18,600 New	18,600 $11,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.